People

Former Arranta Bio CEO David Stevens has joined CDMO Kindeva Drug Delivery as Chief Commercial Officer, the company said. Prior to Arranta, Stevens held a variety of roles at Albany Molecular Research, Aptuit, and Charles River Laboratories. Kindeva (formerly 3M Drug Delivery Systems) merged with Meridian Medical Technologies in late 2022. The company's recent … [Read more...] about Kindeva Drug Delivery names David Stevens as Chief Commercial Officer

MannKind Corporation has named former Acorda Therapeutics COO Lauren Sabella  as Executive VP, Chief Operating Officer. Sabella's experience includes 12 years at Acorda, first as Chief Commercial Officer and then as COO; she previously served in a number of roles at Boehringer Ingelheim, including as Executive Director of Marketing for the Respiratory Franchise and as … [Read more...] about MannKind names Lauren Sabella as Executive VP, COO

Utuly intranasal epinephrine developer Bryn Pharma has named Sandy Loreaux as CEO, succeeding David Dworaczyk, who will remain with the company as head of R&D, regulatory, and production. Loreaux was most recently US President of Covis Pharma and previously held executive positions at Mallinckrodt, Valeant, and Sanofi-Aventis. Bryn recently announced results … [Read more...] about Bryn Pharma names Sandy Loreaux as CEO

AuraVax Therapeutics, which is developing intranasal antiviral technology licensed from Massachusetts General Hospital and the University of Houston, has named former Merck executive Joseph C. Sullivan as the company's first CEO. Sullivan was most recently Chief Commercial Officer at Nature's Toolbox and previously served in various roles at Merck in vaccines, … [Read more...] about AuraVax names Joseph Sullivan as CEO

Inhaled drug developer Savara has announced the appointments of former Strongbridge Biopharma executives Scott Wilhoit as Executive VP, Global Commercial, and Rob Lutz as Chief Operating Officer. The company also said that it had promoted Dave Lowrance from Chief Financial Officer to Chief Financial and Administrative Officer. Wilhoit, who has been a part-time … [Read more...] about Savara announces management changes

PureIMS has appointed Frank Lambert as Executive Director Commercialization. Lambert, who was most recently Executive Director of Business Development for Early Development Services at ICON, will lead commercialization efforts for the company's Cyclops pre-filled disposable dry powder inhaler. PureIMS has Cyclops DPI formulations of levodopa, epinephrine, and … [Read more...] about PureIMS names Frank Lambert Executive Director of Commercialization

TFF Pharmaceuticals, which is developing dry powder inhaled and nasal formulations based on its thin film freezing particle engineering technology, has announced the appointment of Zamaneh Mikhak as Chief Medical Officer. Mikhak was most recently Senior VP and Head of Clinical Development at Cogent Biosciences, and her prior industry experience includes roles at … [Read more...] about TFF Pharmaceuticals names Zamaneh Mikhak as Chief Medical Officer

Inhaled antiviral developer Pneumagen has announced the appointment of Adaptimmune Therapeutics founder James Noble as non-executive Chairman of the company's board of directors. Noble also co-founded Immunocore and serves as Chairman of Sutura Therapeutics, Celleron, and Orexo. In August 2022, Pneumagen initiated a Phase 2 challenge study of its Neumifil … [Read more...] about James Noble named Pneumagen Chairman of the Board